Seeking AlphaWed, 01 Apr 2026 08:32:04 GMTORIC Pharmaceuticals, Inc. (ORIC) Discusses Rinzimetostat Dose Optimization Data and Phase III Trial Design in Metastatic Prostate Cancer TranscriptORIC+0.45%
Zacks Investment ResearchMon, 09 Mar 2026 14:55:55 GMTAfter Golden Cross, Oric Pharmaceuticals, Inc. (ORIC)'s Technical Outlook is BrightORIC+0.45%
Zacks Investment ResearchThu, 26 Feb 2026 15:56:41 GMTWall Street Analysts Believe Oric Pharmaceuticals (ORIC) Could Rally 58.43%: Here's is How to TradeORIC+0.45%
Seeking AlphaWed, 18 Feb 2026 22:14:59 GMTORIC Pharmaceuticals, Inc. (ORIC) Presents at Citi's 2026 Virtual Oncology Leadership Summit TranscriptORIC+0.45%
